Answers are grounded in this paper and cite their sources.
The treatment efficacy of desvenlafaxine 100 mg/day achieved on week 12 in postmenopausal women with vasomotor symptoms is maintained for 1 year.
No takes yet. Share an insight, caveat, or question.
Pinkerton et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: